8-K: Avery Dennison CFO Returns from Medical Leave; Executive Compensation Details Released

Gregory S. Lovins resumes his role as CFO of Avery Dennison on April 1, 2025, after a medical leave, while Danny G. Allouche transitions back to his role as Senior Vice President and Chief Strategy and Corporate Development Officer.

Summary

• Gregory S. Lovins will resume his position as Senior Vice President and Chief Financial Officer of Avery Dennison Corporation on April 1, 2025.
• He is returning from a medical leave of absence that began on November 14, 2024.
• Danny G. Allouche will cease serving as Interim Chief Financial Officer and principal financial officer on March 31, 2025.
• Allouche will continue his role as Senior Vice President and Chief Strategy and Corporate Development Officer.
• In February 2025, the Talent and Compensation Committee approved a base salary of $838,500 for Mr. Lovins.
• His target Annual Incentive Plan opportunity remains at 75% of his base salary, and his target long-term incentive opportunity remains at 250% of his base salary.
• Mr. Lovins will continue to receive an annual executive benefit allowance of $65,000.
• He remains eligible to participate in the company's savings (401(k)), deferred compensation, executive severance, and key employee change of control severance plans.

Sentiment

Score: 7

Explanation: The announcement is neutral to positive, indicating a return to normalcy with the CFO's return and transparent disclosure of compensation details. There are no indications of negative performance or concerns.

Positives

• The return of Gregory S. Lovins as CFO provides stability and continuity in the company's financial leadership.
• Danny G. Allouche's continued role as Senior Vice President and Chief Strategy and Corporate Development Officer ensures ongoing focus on strategic initiatives.
• Executive compensation details are transparently disclosed.

Future Outlook

The document does not contain specific forward-looking statements regarding financial performance or strategic direction beyond the executive changes.

Industry Context

This announcement is typical for publicly traded companies, disclosing changes in key personnel and their compensation as part of corporate governance and transparency requirements.

Comparison to Industry Standards

• Executive compensation packages at Avery Dennison, including base salary, incentive plans, and benefits, are likely benchmarked against peer companies in the materials science and manufacturing sectors.
• Companies like 3M, DuPont, and Illinois Tool Works (ITW) often serve as comparables for executive compensation analysis.
• The specific details of Avery Dennison's compensation structure would be compared to these peers to ensure competitiveness and alignment with performance goals.

Management Changes

Stakeholder Impact

• Shareholders may view the return of the CFO positively, as it signals stability in financial leadership.
• Employees may be reassured by the continuity in executive roles.
• The transparent disclosure of executive compensation aligns with good corporate governance practices.

Key Dates

Keywords

CFO, Gregory S. Lovins, Danny G. Allouche, Executive Compensation, Medical Leave, Avery Dennison, Financial Officer, Corporate Governance